Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Melatonin (Primary)
- Indications Neurological disorders; Sleep disorders
- Focus Therapeutic Use
- Acronyms MIND
- 28 Jun 2018 Biomarkers information updated
- 04 Feb 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 01 Jan 2013 Planned End Date changed from 1 Oct 2017 to 1 Jan 2018 as reported by ClinicalTrials.gov.